Shanghai Bao Pharma Sets 28 Aug 2026 Board Meeting to Review H1 Results

Bulletin Express

08/18

Shanghai Bao Pharmaceuticals Co., Ltd. announced that its Board of Directors will convene on Friday, 28 August 2026. The meeting’s primary agenda is to review and approve the interim financial results for the six months ended 30 June 2026 and authorize their subsequent publication. Additional matters may also be considered during the session.

The Board is currently composed of Executive Directors Dr. Liu Yanjun (Chairman), Ms. Wang Zheng and Ms. Li Cui; Employee Representative Director Mr. Sun Yuhua; Non-Executive Directors Ms. Lin Chia-ling, Mr. Diao Juanhuan and Mr. Li Chen; and Independent Non-Executive Directors Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen and Mr. Zhang Senquan.

The company released the notice from its Shanghai headquarters on 18 August 2026, underscoring procedural transparency ahead of its mid-year earnings disclosure.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1171121109"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1171121109\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1171121109?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171121109","market":"us","top_or_hot":-1,"title":"Shanghai Bao Pharma Sets 28 Aug 2026 Board Meeting to Review H1 Results","media":"Bulletin Express","content":"<p>Shanghai Bao Pharmaceuticals Co., Ltd. announced that its Board of Directors will convene on Friday, 28 August 2026. The meeting’s primary agenda is to review and approve the interim financial results for the six months ended 30 June 2026 and authorize their subsequent publication. Additional matters may also be considered during the session.</p>\n<p>The Board is currently composed of Executive Directors Dr. Liu Yanjun (Chairman), Ms. Wang Zheng and Ms. Li Cui; Employee Representative Director Mr. Sun Yuhua; Non-Executive Directors Ms. Lin Chia-ling, Mr. Diao Juanhuan and Mr. Li Chen; and Independent Non-Executive Directors Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen and Mr. Zhang Senquan.</p>\n<p>The company released the notice from its Shanghai headquarters on 18 August 2026, underscoring procedural transparency ahead of its mid-year earnings disclosure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Bao Pharma Sets 28 Aug 2026 Board Meeting to Review H1 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Bao Pharma Sets 28 Aug 2026 Board Meeting to Review H1 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-18 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Bao Pharmaceuticals Co., Ltd. announced that its Board of Directors will convene on Friday, 28 August 2026. The meeting’s primary agenda is to review and approve the interim financial results for the six months ended 30 June 2026 and authorize their subsequent publication. Additional matters may also be considered during the session.</p>\n<p>The Board is currently composed of Executive Directors Dr. Liu Yanjun (Chairman), Ms. Wang Zheng and Ms. Li Cui; Employee Representative Director Mr. Sun Yuhua; Non-Executive Directors Ms. Lin Chia-ling, Mr. Diao Juanhuan and Mr. Li Chen; and Independent Non-Executive Directors Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen and Mr. Zhang Senquan.</p>\n<p>The company released the notice from its Shanghai headquarters on 18 August 2026, underscoring procedural transparency ahead of its mid-year earnings disclosure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02659","symbol_name":"宝济药业-B","start_time":0,"source_url":"","article_id":"1171121109","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171121109","pubTimestamp":1787042895,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Bao Pharmaceuticals Co., Ltd. announced that its Board of Directors will convene on Friday, 28 August 2026. The meeting’s primary agenda is to review and approve the interim financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02659":"宝济药业-B"},"translate_title":"上海宝医药定于 2026 年 8 月 28 日召开董事会审查上半年业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1},"content_text":"Shanghai Bao Pharmaceuticals Co., Ltd. announced that its Board of Directors will convene on Friday, 28 August 2026. The meeting’s primary agenda is to review and approve the interim financial results for the six months ended 30 June 2026 and authorize their subsequent publication. Additional matters may also be considered during the session.\nThe Board is currently composed of Executive Directors Dr. Liu Yanjun (Chairman), Ms. Wang Zheng and Ms. Li Cui; Employee Representative Director Mr. Sun Yuhua; Non-Executive Directors Ms. Lin Chia-ling, Mr. Diao Juanhuan and Mr. Li Chen; and Independent Non-Executive Directors Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen and Mr. Zhang Senquan.\nThe company released the notice from its Shanghai headquarters on 18 August 2026, underscoring procedural transparency ahead of its mid-year earnings disclosure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}